A detailed history of Artisan Partners Limited Partnership transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 391,842 shares of AGIO stock, worth $21.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
391,842
Previous 320,467 22.27%
Holding current value
$21.8 Million
Previous $13.8 Million 25.99%
% of portfolio
0.03%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$41.19 - $49.72 $2.94 Million - $3.55 Million
71,375 Added 22.27%
391,842 $17.4 Million
Q2 2024

Aug 12, 2024

BUY
$27.55 - $48.83 $8.83 Million - $15.6 Million
320,467 New
320,467 $13.8 Million
Q1 2021

May 11, 2021

SELL
$44.23 - $57.5 $18.3 Million - $23.8 Million
-414,598 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$33.21 - $46.54 $2.63 Million - $3.68 Million
79,059 Added 23.56%
414,598 $18 Million
Q3 2020

Nov 12, 2020

BUY
$33.87 - $55.93 $2.5 Million - $4.14 Million
73,958 Added 28.27%
335,539 $11.7 Million
Q2 2020

Aug 12, 2020

BUY
$34.45 - $53.48 $3.14 Million - $4.88 Million
91,163 Added 53.49%
261,581 $14 Million
Q1 2020

May 12, 2020

BUY
$31.52 - $53.81 $5.37 Million - $9.17 Million
170,418 New
170,418 $6.05 Million
Q4 2019

Feb 12, 2020

SELL
$30.08 - $50.59 $11.7 Million - $19.7 Million
-389,596 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$32.4 - $49.58 $662,806 - $1.01 Million
20,457 Added 5.54%
389,596 $12.6 Million
Q2 2019

Aug 09, 2019

BUY
$46.17 - $68.1 $8.85 Million - $13.1 Million
191,729 Added 108.07%
369,139 $18.4 Million
Q1 2019

May 10, 2019

BUY
$45.92 - $67.67 $3.63 Million - $5.35 Million
79,011 Added 80.3%
177,410 $12 Million
Q4 2018

Feb 12, 2019

BUY
$42.73 - $76.53 $4.2 Million - $7.53 Million
98,399 New
98,399 $4.54 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.05B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.